Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLOX-PEN: Phase II Clinical Trial to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy

NCT07285356 is registered in ClinicalTrials.gov with AC Camargo Cancer Center as lead sponsor.

NCT NCT07285356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07285356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLOX-PEN: Phase II Clinical Trial to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
Lead sponsor
AC Camargo Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
October 6, 2025
Completion date
September 18, 2026
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, oxaliplatin-induced peripheral neuropathy